Clinical trials are essential to the evaluating the safety and efficacy of new therapies.
For more information, follow the link to study listings on ClinicalTrials.gov.
Process for requesting expanded access.
Patients interested in seeking expanded access to a scPharmaceuticals investigational product should talk to their physician.
A treating physician may request information about how to request access to one of scPharmaceuticals’ investigational products by contacting scPharmaceuticals Medical Information:
email@example.com; +1 855-SCPHARMA (855-727-4276)
scPharmaceuticals will acknowledge receipt of a request for expanded access within three business days and our experts will carefully review all expanded access requests in consideration of the above criteria. All physicians who receive scPharmaceuticals investigational product through expanded access are required to comply with all applicable laws and regulations, and contractual conditions, including those relating to safety reporting.
Investigator-sponsored Studies (ISS)
For more information on our ISS program, please email firstname.lastname@example.org.
At scPharmaceuticals, we believe the future of healthcare lies within the talents of today’s scientists and technologists. With the goal of expanding skills and knowledge to improve standards of care and patient outcomes in the treatment of cardiovascular and infectious diseases, scPharmaceuticals may provide support for independent accredited and non-accredited educational activities for healthcare professionals.
Request Medical Information
We are committed to providing current, balanced, and accurate scientific information related to scPharmaceuticals’ products.
To submit a medical information request, please complete the form below and/or contact us at: 855-SCPHARMA (855-727-4272)